Abstract
IntroductionLowering of low-density lipoprotein (LDL) levels is known to reduce the risk of cardiovascular events in patients with known atherosclerotic cardiovascular disease (ASCVD). The 2021 European Society of Cardiology (ESC)...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
